Expression of CD44 isoforms in human prostate tumor cell lines

Prostate

Volumn 28, Issue 3, 1996, Pages 153-161

  Stevens, Jeff W ^a   Palechek, Patricia L ^a   Griebling, Tomas L ^a   Midura, Ronald J ^a   Rokhlin, Oskar W ^a   Cohen, Michael B ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

CD44; prostatic neoplasms; RT PCR

Indexed keywords

DNA; HERMES ANTIGEN; ISOPROTEIN; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY;

ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD44; BASE SEQUENCE; BLOTTING, WESTERN; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0029892401     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(199603)28:3<153::AID-PROS2>3.0.CO;2-G     Document Type: Article

References (27)

1. Haynes BF, Liao HX, Patton KL: The transmembrane hyaluronate receptor (CD44): Multiple functions, multiple forms. Cancer Cells 3:347-350, 1991.
2. Hart IR, Birch M, Marshall JF: Cell adhesion receptor expression during melanoma progression and metastases. Cancer Metastasis Rev 10:115-128, 1991.
3. Sy MS, Guo YJ, Stamenkovic I: Distinct effects of two CD44 isoforms on tumor growth in vivo. J Exp Med 174:859-866, 1991.
4. Thomas L, Byers HR, Vink J, Stamenkovic I: CD44H regulates tumor cell migration on hyaluronate-coated substrate. J Cell Biol 118:971-977, 1992.
5. Arch R, Wirth K, Hofmann M, Ponta H, Matzku S, Herrlich P, Zöller M: Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science 257:682-685, 1992.
6. Günthert U: CD44: A multitude of isoforms with diverse functions. Curr Top Microbiol Immunol 184:47-63, 1993.
7. East JA, Hart IR: CD44 and its role in tumour progression and metastasis. Eur J Cancer 29A:1921-1922, 1993.
8. Screaton GR, Bell MV, Bell JI, Jackson DG: The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. J Biol Chem 268:12235-12238, 1993.
9. Screaton GR, Bell MV, Jackson DG, Cornelius FB, Gerth U, Bell JI: Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 89:12160-12164, 1992.
10. Jackson DG, Buckley J, Bell JI: Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain. J Biol Chem 367:4732-4739, 1992.
11. Matsumura Y, Tarin D: Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 340:1053-1058, 1992.
12. Salles G, Zain M, Wei-meng J, Vassiliki AB, Shipp MA: Alternatively spliced CD44 transcripts in diffuse large-cell lymphomas: Characterization and comparison with normal activated B cells and epithelial malignancies. Blood 82:3539-3547, 1993.
13. Wielenga JM, Heider K-H, Johan G, Offerhaus JA, Günther RA, van den Berg FM, Ponta H, Herrlich P, Pals ST: Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 53:4754-4756, 1993.
14. Mayer B, Jauch KW, Günthert U, Figdor CG, Schildberg FW, Funke I, Johnson JP: Denovo expression of CD44 and survival in gastric cancer. Lancet 342:1019-1022, 1993.
15. Salmi M, Grön-Virta K, Sointu P, Grenman R, Kalimo H, Jalkanen S: Regulated expression of exon v6 containing isoforms of CD44 in man: Down-regulation during malignant transformation of tumors of squamocellular origin. J Cell Biol 122:431-442, 1993.
16. Rokhlin OW, Cohen MB: Expression of cellular adhesion molecules on human prostate tumor cell lines. Prostate (in press).
17. Narayan P, Dahiya R: Establishment and characterization of a human primary prostate adenocarcinoma cell line (ND-1). J Urol 148:1000-1004, 1992.
18. Ujiie K: mRNA expression and synthesis of endothelin-1 along rat nephron segment. J Clin Invest 90:1043-1048, 1992.
19. Sambrook J, Fritsch EF, Maniatis T: "Molecular Cloning. A Laboratory Manual." Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
20. Borner C, Guadagno SN, Fabbro D, Weinstein IB: Expression of four protein kinase C isoforms in rat fibroblasts. J Biol Chem 267:12892-12899, 1992.
21. Liu AY: Expression of CD44 in prostate cancer cells. Cancer Lett 76:63-69, 1992.
22. Günthert U, Hofmann M, Wolfgang R, Reber S, Zöller M, Haubmann I, Matzku S, Wenzel A, Ponta H, Herrlich P: A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65:13-24, 1991.
23. Knudson W, Biswas C, Li XQ, Nemec RE, Toole BP: The role and regulations of tumour-associated hyaluronan. In Evered D, Whelan J (eds): "The Biology of Hyaluronan." New York: Wiley, Chichester, 1989, pp 150-169.
24. Underhill C: CD44: The hyaluronan receptor. J Cell Sci 103:293-298, 1992.
25. Lokeshwar VB, Bourguignon L: The lymphoma transmembrane glycoprotein GP85 (CD44) is a novel guanine nucleotide-binding protein which regulates GP85 (CD44) ankyrin interaction. J Biol Chem 267:22073-22078, 1992.
26. Hofmann M, Rudy W, Günthert U, Zimmer SG, Zawadzki V, Zöller M, Lichtner RB, Herrlich P, Ponta H: A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells. Cancer Res 53:1516-1521, 1993.
27. Mackay CR, Terpe HJ, Stauder R, Marston W, Stark H, Günthert U: Expression and modulation of CD44 variant isoforms in humans. J Cell Biol 124:71-82, 1994.